Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Prostatic Neoplasms 22Breast Neoplasms 21Polycystic Ovary Syndrome 12Carcinoma, Non-Small-Cell Lung 11Colorectal Neoplasms 10Lung Neoplasms 8Endometrial Neoplasms 7Pancreatic Neoplasms 6Neoplasms 6Glioblastoma 5Rectal Neoplasms 4Melanoma 4Lymphoma, Large B-Cell, Diffuse 4Insulin Resistance 4Adenocarcinoma of Lung 4Adenocarcinoma 4Uterine Cervical Neoplasms 3Leukoplakia, Oral 3Urinary Bladder Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Obesity 2Neoplasm Metastasis 2Liver Neoplasms 2Leukemia, Myeloid, Acute 2Hyperandrogenism 2Esophageal Neoplasms 2Erythroplasia 2Endometrial Hyperplasia 2Diabetes Mellitus 2Colonic Neoplasms 2

Interventions

Exercise 12Methods 2Diet 2Behavior Therapy 2secukinumab 1peficitinib 1lime 1cytisine 1Waiting Lists 1Telemedicine 1Spirometry 1Self-Management 1Resistance Training 1Professional Autonomy 1Nutrition Assessment 1Metformin 1Memantine 1High-Intensity Interval Training 1Hematologic Tests 1Health 1Exergaming 1Diet Therapy 1Counseling 1Clinical Trials as Topic 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Motor Activity × Metformin × Clear all
NCT01340300 2018-06-06

Exercise and Metformin in Colorectal and Breast Cancer Survivors

Dana-Farber Cancer Institute

Phase 2 Completed
139 enrolled 18 charts
BreastGastrointestinal

Breast Neoplasms, Insulin Resistance, Motor Activity, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡